SUMMARY To examine the role of the sympathetic nervous system in hypertension, the in vitro activity of tyrosine hydroxylase was examined in one-kidney, one dip (1K1C) and two-kidney, one dip (2K1C) hypertensive rabbits and their respective controls 2 weeks after surgical procedures. The in vitro activity of tyrosine hydroxylase provides a measure of catecholamine synthesis and serves as a biochemical index of activity of noradrenergic neurons and the adrenal medulla. Mean arterial pressure rose from 91.5 ± 1.0 to 125.5 ± 5.6 mm Hg (p < 0.01) in the 1K1C group and from 91.8 ± 1.3 to 106.5 ± 5.0 mm Hg (p < 0.02) hi the 2K1C group, whereas no change in blood pressure was found in their respective controls. Adrenal tyrosine hydroxylase activity was increased 85% in the 1K1C group, as compared with values in one-kidney controls (from 11.8 ± 1.5 to 21.8 ± 1.1 pmol COj/mln/mg; p < 0.0002), and was increased 49% in the 2K1C group, as compared with values in two-kidney controls (from 8.01 ± 1.2 to 11.9 ± 1 . 1 pmol COj/min/mg; p < 0.02). In the 1K1C group, proximal mesenteric tyrosine hydroxylase activity was decreased 46% compared with values in one-kidney controls (from 23.5 ± 5.0 to 12.8 ± 2.5 pmol CO]/ min/mg; p < 0.03) and distal mesenteric tyrosine hydroxylase activity was decreased 42% (from 7.73 ± 1.2 to 4.46 ± 0.8 pmol COj/mln/mg; p < 0.03). In the 2K1C group, neither proximal nor distal mesenteric tyrosine hydroxylase activity was altered. Tyrosine hydroxylase activity was not detectable in the femoral arteries, or hi the thoracic and abdominal aorta. These results indicate that the adrenal medulla contributes to the patbophysioJogy of both 1K1C and 2K1C forms of hypertension. These results also indicate that alterations hi the sympathetic nervous system in 1K1C hypertension are not mediated by an activation of tyrosine hydroxylase in the mesenteric arteries. of diseases that are collectively characterized by an elevated systemic blood pressure. Efforts to reduce the risk of cardiovascular complications in hypertension have focused on the treatment of the elevated blood pressure; however, blood pressure is not the sole determinant for cardiovascular complications in hypertension.1 In experimental models of hypertension, the elevation in blood pressure cannot predict the occurrence of necrotizing arteritis 2 -3 and cerebral hemorrhages 6 or the degree of vascular 3 -7 and cardiac hypertrophy. 8 -1 ' The identity of other determinants for cardiovascular complications in experimental models of hypertension is unknown. Identification of these determinants would aid not only in understanding the pathogenesis of cardiovascular disease but also in developing more efficacious treatments for hypertension. The sympathetic nervous system (SNS) participates in the regulation of blood pressure and plays a key role in the pathophysiology of hypertension. The development of one-kidney, one clip (1K.1C) hypertension, a model of hypertension with a high incidence of cardiovascular complications, 5 is associated with a variety ...